(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(-0.04%) $83.33
(1.21%) $1.834
(-0.31%) $2 334.80
(-0.28%) $27.29
(-0.33%) $919.80
(-0.04%) $0.934
(-0.03%) $10.90
(-0.05%) $0.803
(0.00%) $93.19
Live Chart Being Loaded With Signals
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies...
Stats | |
---|---|
Today's Volume | 60 700.00 |
Average Volume | 261 654 |
Market Cap | 30.17B |
EPS | HKD0 ( 2023-10-30 ) |
Last Dividend | HKD1.983 ( 2023-06-15 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 8.69 |
ATR14 | HKD0.113 (0.19%) |
Volume Correlation
Asymchem Laboratories Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Asymchem Laboratories Correlation - Currency/Commodity
Asymchem Laboratories Financials
Annual | 2023 |
Revenue: | HKD7.83B |
Gross Profit: | HKD4.00B (51.16 %) |
EPS: | HKD0 |
Q4 | 2023 |
Revenue: | HKD1.44B |
Gross Profit: | HKD548.42M (38.03 %) |
EPS: | HKD0 |
Q3 | 2023 |
Revenue: | HKD1.76B |
Gross Profit: | HKD1.00B (56.91 %) |
EPS: | HKD0 |
Q2 | 2023 |
Revenue: | HKD2.37B |
Gross Profit: | HKD1.36B (57.49 %) |
EPS: | HKD0 |
Financial Reports:
No articles found.
Asymchem Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD1.983 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.671 | 2022-06-13 |
Last Dividend | HKD1.983 | 2023-06-15 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD2.65 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.38 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.25 | |
Div. Directional Score | 9.54 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6078.HK | Ex Dividend Junior | 2023-06-30 | Annually | 0 | 0.00% | |
1846.HK | Ex Dividend Knight | 2023-09-11 | Annually | 0 | 0.00% | |
0869.HK | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
0023.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
2638.HK | Ex Dividend Junior | 2023-08-15 | Semi-Annually | 0 | 0.00% | |
1417.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
0506.HK | Ex Dividend Knight | 2023-06-13 | Annually | 0 | 0.00% | |
6837.HK | Ex Dividend Junior | 2023-06-30 | Annually | 0 | 0.00% | |
1963.HK | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% | |
0995.HK | Ex Dividend Junior | 2023-06-13 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.290 | 1.500 | 4.20 | 6.30 | [0 - 0.5] |
returnOnAssetsTTM | 0.115 | 1.200 | 6.17 | 7.41 | [0 - 0.3] |
returnOnEquityTTM | 0.133 | 1.500 | 9.63 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0238 | -1.000 | 9.76 | -9.76 | [0 - 1] |
currentRatioTTM | 6.86 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.23 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.95 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00745 | -1.500 | 9.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 434.87 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.54 | 2.00 | 8.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.150 | 2.00 | 9.93 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00842 | -1.500 | 9.97 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.512 | 1.000 | 4.81 | 4.81 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.329 | 1.000 | 5.43 | 5.43 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 8.81 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.396 | 0.800 | -0.694 | -0.555 | [0.5 - 2] |
Total Score | 12.82 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 9.00 | 1.000 | 9.19 | 0 | [1 - 100] |
returnOnEquityTTM | 0.133 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.150 | 2.00 | 9.95 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.56 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.54 | 2.00 | 8.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0238 | 1.500 | 9.76 | -9.76 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.166 | 1.000 | 8.36 | 0 | [0.1 - 0.5] |
Total Score | 6.25 |
Asymchem Laboratories
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators